The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: A population based study

Journal of Urology

Volumn 166, Issue 5, 2001, Pages 1672-1678

  Borque, A ^a,b   Sanz, G ^a,b   Allepuz, C ^a,b   Plaza, L ^a,b   Gil, P ^a,b   Rioja, L A ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Logistic models; Neoplasm staging; Neural networks (computer); Prostate; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER STAGING; CANCER SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; REGRESSION ANALYSIS; STATISTICAL MODEL;

EID: 0034789548     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65651-0     Document Type: Article

References (47)

1. Risk factors for prostate and testicular cancer
2. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States
3. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
4. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
5. Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks
6. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma
7. Seminal vesicle biopsy in prostate cancer staging
8. Valor y secuencia de la biopsia de vesfculas seminales y la linfadenectomía pelviana laparoscópica en el estadiaje del cáncer de próstata
9. Histological grading of prostatic carcinoma
10. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
11. The meaning and use of the area under a receiver operating characteristic (ROC) curve
12. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate
13. Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade
14. The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer
15. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
16. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer
17. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
18. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer
19. Clinical stage, prostate-specific antigen and Gleason grade to predict extracapsular disease or nodal metastasis in men with newly diagnosed, previously untreated prostate cancer. A multicenter study
20. Factores pronósticos y tablas predictivas del cáncer de próstata no localizado que excluirían la realización de la prostatectomía radical
21. Prostatectomía radical en adenocarcinoma de próstata. Factores clínicos influyentes en el estadio patológico. Modelo diagnóstico
22. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: Results from the population based prostate cancer outcomes study
23. Predictive value of contralateral biopsies in unilaterally palpable prostate cancer
24. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels
25. Dietary factors and risks for prostate cancer among blacks and whites in the United States
26. The epidemiology of prostate cancer part II: The risk factors
27. Artificial neural networks in the diagnosis and prognosis of prostate cancer: A pilot study
28. Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks
29. Pathology of adenocarcinoma of the prostate
30. Histologic grading of prostate cancer: A perspective
31. Report on prostate cancer tumor marker workshop 1999
32. Applications of neural networks in urologic oncology
33. Evaluation of neural networks performance by receiver operating characteristic (ROC) analysis: Examples from the biotechnology domain
34. Generating ROC curves for artificial neural networks
35. Prediction and cross-validation of neural networks versus logistic regression: Using hepatic disorders as an example
36. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology
37. Predicting hospital mortality for patients in the intensive care unit: A comparison of artificial neural networks with logistic regression models
38. Comparison of artificial neural networks with logistic regression in prediction of in-hospital death after percutaneous transluminal coronary angioplasty
39. Visualisation of biomedical datasets by use of growing cell structure networks: A novel diagnostic classification technique
40. Comparison of multiple prediction models for ambulation following spinal cord injury
41. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses
42. Prediction and cross-validation of neural networks versus logistic regression: Using hepatic disorders as an example
43. Predicting mortality after coronary artery bypass surgery: What do artificial neural networks learn?
44. Artificial neural network for predicting intracranial haemorrhage in preterm neonates
45. Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm